MYC and breast cancer: Therefore, blocking of the LIN28B/MYC/miR-34a-5p signaling pathway, by the LIN28B specific inhibitor, causes a dramatic inhibition of tumor growth and metastatic potential in orthotopic immunodeficient mouse models of human breast cancer cells [156].